{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:23:34Z","timestamp":1782779014761,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pneumonia"],"DOI":"10.1186\/s41479-025-00193-9","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:03:24Z","timestamp":1771977804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Biomarker-guided use of corticosteroids in pneumonia"],"prefix":"10.1186","volume":"18","author":[{"given":"Abel","family":"Soriano Puig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Monforte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Camprub\u00ed-Rimblas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Artigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"Ceccato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"issue":"10513","key":"193_CR1","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/S0140-6736(25)01917-8","volume":"406","author":"M Naghavi","year":"2025","unstructured":"Naghavi M, Kyu HH, Aalipour AB, Aalruz MA, Ababneh H. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990\u20132023: a systematic analysis for the global burden of disease study 2023. Lancet. 2025;406(10513):1811\u201372.","journal-title":"Lancet"},{"issue":"25","key":"193_CR2","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1056\/NEJMp1113569","volume":"366","author":"DS Jones","year":"2012","unstructured":"Jones DS, Podolsky SH, Greene JA. The burden of disease and the changing task of medicine. N Engl J Med. 2012;366(25):2333\u20138.","journal-title":"N Engl J Med"},{"issue":"12","key":"193_CR3","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1001\/jama.2018.2089","volume":"27","author":"C El Bcheraoui","year":"2018","unstructured":"El Bcheraoui C, Mokdad AH, Dwyer-Lindgren L, Bertozzi-Villa A, Stubbs RW, Morozoff C, et al. Trends and patterns of differences in infectious disease mortality among US Counties, 1980\u20132014. JAMA. 2018;27(12):1248\u201360.","journal-title":"JAMA"},{"issue":"5840","key":"193_CR4","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/bmj.4.5840.569","volume":"4","author":"VU McHardy","year":"1972","unstructured":"McHardy VU, Schonell ME. Ampicillin dosage and use of prednisolone in treatment of pneumonia: Co-operative controlled trial. Br Med J. 1972;4(5840):569\u201373.","journal-title":"Br Med J"},{"issue":"4","key":"193_CR5","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.ccm.2018.07.008","volume":"39","author":"A Ceccato","year":"2018","unstructured":"Ceccato A, Ferrer M, Barbeta E, Torres A. Adjunctive therapies for Community-Acquired pneumonia. Clin Chest Med. 2018;39(4):753\u201364.","journal-title":"Clin Chest Med"},{"issue":"6","key":"193_CR6","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s00134-025-07947-5","volume":"51","author":"J Helms","year":"2025","unstructured":"Helms J, Ferrer R, Torres A. Corticosteroids in non-viral community-acquired pneumonia: edging closer to yes. Intensive Care Med. 2025;51(6):1139\u201341.","journal-title":"Intensive Care Med"},{"key":"193_CR7","doi-asserted-by":"crossref","unstructured":"Jones BE, Ramirez JA, Oren E, Soni NJ, Sullivan LR, Restrepo MI, et al. Diagnosis and management of community-acquired pneumonia. an official american thoracic society clinical practice guideline. Am J Respir Crit Care Med. 2025.","DOI":"10.1164\/rccm.202507-1692ST"},{"issue":"5","key":"193_CR8","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00134-025-07912-2","volume":"51","author":"T Pitre","year":"2025","unstructured":"Pitre T, Pauley E, Chaudhuri D, Saha R, Rudd KE, Villar J, et al. Corticosteroids for adult patients hospitalised with non-viral community-acquired pneumonia: a systematic review and meta-analysis. Intensive Care Med. 2025;51(5):917\u201329.","journal-title":"Intensive Care Med"},{"key":"193_CR9","doi-asserted-by":"publisher","first-page":"154507","DOI":"10.1016\/j.jcrc.2023.154507","volume":"80","author":"HA Cheema","year":"2024","unstructured":"Cheema HA, Musheer A, Ejaz A, Paracha AA, Shahid A, Rehman MEU, et al. Efficacy and safety of corticosteroids for the treatment of community-acquired pneumonia: A systematic review and meta-analysis of randomized controlled trials. J Crit Care. 2024;80:154507.","journal-title":"J Crit Care"},{"issue":"22","key":"193_CR10","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa2507100","volume":"393","author":"RK Lucinde","year":"2025","unstructured":"Lucinde RK, Gathuri H, Mwaniki P, Orindi B, Otieno EO, Mwakio S, et al. A pragmatic trial of glucocorticoids for Community-Acquired pneumonia. N Engl J Med. 2025;393(22):2187\u201397.","journal-title":"N Engl J Med"},{"issue":"21","key":"193_CR11","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","volume":"388","author":"PF Dequin","year":"2023","unstructured":"Dequin PF, Meziani F, Quenot JP, Kamel T, Ricard JD, Badie J, et al. Hydrocortisone in severe Community-Acquired pneumonia. N Engl J Med. 2023;388(21):1931\u201341.","journal-title":"N Engl J Med"},{"issue":"5","key":"193_CR12","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S2213-2600(23)00430-7","volume":"12","author":"N Heming","year":"2024","unstructured":"Heming N, Renault A, Kuperminc E, Brun-Buisson C, Megarbane B, Quenot JP, et al. Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial. Lancet Respiratory Med. 2024;12(5):366\u201374.","journal-title":"Lancet Respiratory Med"},{"issue":"4","key":"193_CR13","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00134-025-07861-w","volume":"51","author":"DC Angus","year":"2025","unstructured":"Angus DC. Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia. Intensive Care Med. 2025;51(4):665\u201380.","journal-title":"Intensive Care Med"},{"issue":"8","key":"193_CR14","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00134-022-06684-3","volume":"48","author":"GU Meduri","year":"2022","unstructured":"Meduri GU, Shih MC, Bridges L, Martin TJ, El-Solh A, Seam N, et al. Low-dose Methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia. Intensive Care Med. 2022;48(8):1009\u201323.","journal-title":"Intensive Care Med"},{"issue":"4","key":"193_CR15","doi-asserted-by":"publisher","first-page":"2200735","DOI":"10.1183\/13993003.00735-2022","volume":"61","author":"I Martin-Loeches","year":"2023","unstructured":"Martin-Loeches I, Torres A, Nagavci B, Aliberti S, Antonelli M, Bassetti M, et al. ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia. Eur Respir J. 2023;61(4):2200735.","journal-title":"Eur Respir J"},{"issue":"5","key":"193_CR16","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1097\/CCM.0000000000006172","volume":"52","author":"D Chaudhuri","year":"2024","unstructured":"Chaudhuri D, Nei AM, Rochwerg B, Balk RA, Asehnoune K, Cadena R, et al. 2024 focused update: guidelines on use of corticosteroids in Sepsis, acute respiratory distress Syndrome, and Community-Acquired pneumonia. Crit Care Med. 2024;52(5):e219.","journal-title":"Crit Care Med"},{"issue":"6","key":"193_CR17","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1183\/09031936.00060112","volume":"41","author":"MS Paats","year":"2013","unstructured":"Paats MS, Bergen IM, Hanselaar WEJJ, van Groeninx EC, Hoogsteden HC, Hendriks RW, et al. Local and systemic cytokine profiles in nonsevere and severe community-acquired pneumonia. Eur Respir J. 2013;41(6):1378\u201385.","journal-title":"Eur Respir J"},{"issue":"4","key":"193_CR18","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1007\/s10753-014-9840-2","volume":"37","author":"R Fernandez-Botran","year":"2014","unstructured":"Fernandez-Botran R, Uriarte SM, Arnold FW, Rodriguez-Hernandez L, Rane MJ, Peyrani P, et al. Contrasting inflammatory responses in severe and non-severe community-acquired pneumonia. Inflammation. 2014;37(4):1158\u201366.","journal-title":"Inflammation"},{"issue":"1","key":"193_CR19","doi-asserted-by":"publisher","first-page":"e1767","DOI":"10.1016\/j.jcrc.2009.05.002","volume":"25","author":"YL Lee","year":"2010","unstructured":"Lee YL, Chen W, Chen LY, Chen CH, Lin YC, Liang SJ, et al. Systemic and Bronchoalveolar cytokines as predictors of in-hospital mortality in severe community-acquired pneumonia. J Crit Care. 2010;25(1):e1767\u201313.","journal-title":"J Crit Care"},{"issue":"10","key":"193_CR20","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1136\/thoraxjnl-2016-209719","volume":"72","author":"LD Bos","year":"2017","unstructured":"Bos LD, Schouten LR, van Vught LA, Wiewel MA, Ong D, Cremer O, et al. Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis. Thorax. 2017;72(10):876\u201383.","journal-title":"Thorax"},{"issue":"11","key":"193_CR21","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1007\/s00134-022-06871-2","volume":"48","author":"A Conway Morris","year":"2022","unstructured":"Conway Morris A, Rynne J, Shankar-Hari M. Compartmentalisation of immune responses in critical illness: does it matter? Intensive Care Med. 2022;48(11):1617\u201320.","journal-title":"Intensive Care Med"},{"issue":"1","key":"193_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13054-016-1250-4","volume":"20","author":"PHC Leliefeld","year":"2016","unstructured":"Leliefeld PHC, Wessels CM, Leenen LPH, Koenderman L, Pillay J. The role of neutrophils in immune dysfunction during severe inflammation. Crit Care. 2016;20(1):73.","journal-title":"Crit Care"},{"issue":"4","key":"193_CR23","first-page":"101253","volume":"42","author":"M Bouras","year":"2023","unstructured":"Bouras M, Rello J, Roquilly A. Steroids in severe community-acquired pneumonia: dangerous, worthless, or miracle cure? The roller coaster of clinical trials. Anaesth Crit Care Pain Med. 2023;42(4):101253.","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"7","key":"193_CR24","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/thx.2008.105312","volume":"64","author":"R Men\u00e9ndez","year":"2009","unstructured":"Men\u00e9ndez R, Mart\u00ednez R, Reyes S, Mensa J, Filella X, Marcos MA, et al. Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax. 2009;64(7):587\u201391.","journal-title":"Thorax"},{"issue":"5","key":"193_CR25","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1136\/thx.2007.086785","volume":"63","author":"R Men\u00e9ndez","year":"2008","unstructured":"Men\u00e9ndez R, Cavalcanti M, Reyes S, Mensa J, Martinez R, Marcos MA, et al. Markers of treatment failure in hospitalised community acquired pneumonia. Thorax. 2008;63(5):447\u201352.","journal-title":"Thorax"},{"issue":"3","key":"193_CR26","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1183\/09031936.00003608","volume":"32","author":"AHW Bruns","year":"2008","unstructured":"Bruns AHW, Oosterheert JJ, Hak E, Hoepelman AIM. Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia. Eur Respir J. 2008;32(3):726\u201332.","journal-title":"Eur Respir J"},{"issue":"2","key":"193_CR27","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1186\/cc11291","volume":"16","author":"LM Coelho","year":"2012","unstructured":"Coelho LM, Salluh JIF, Soares M, Bozza FA, Verdeal JCR, Castro-Faria-Neto HC, et al. Patterns of c-reactive protein RATIO response in severe community-acquired pneumonia: a cohort study. Crit Care. 2012;16(2):R53.","journal-title":"Crit Care"},{"issue":"7","key":"193_CR28","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/jama.2015.88","volume":"313","author":"A Torres","year":"2015","unstructured":"Torres A, Sibila O, Ferrer M, Polverino E, Menendez R, Mensa J, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA. 2015;313(7):677\u201386.","journal-title":"JAMA"},{"issue":"3","key":"193_CR29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-2600(24)00405-3","volume":"13","author":"JM Smit","year":"2025","unstructured":"Smit JM, Zee PAVD, Stoof SCM, Genderen MEV, Snijders D, Boersma WG, et al. Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials. Lancet Respiratory Med. 2025;13(3):221\u201333.","journal-title":"Lancet Respiratory Med"},{"issue":"1","key":"193_CR30","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s13054-021-03840-x","volume":"25","author":"A Ceccato","year":"2021","unstructured":"Ceccato A, Russo A, Barbeta E, Oscanoa P, Tiseo G, Gabarrus A, et al. Real-world corticosteroid use in severe pneumonia: a propensity-score-matched study. Crit Care. 2021;25(1):432.","journal-title":"Crit Care"},{"issue":"1","key":"193_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","volume":"18","author":"P Schuetz","year":"2018","unstructured":"Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, et al. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2018;18(1):95\u2013107.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"193_CR32","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1164\/rccm.200702-307OC","volume":"176","author":"M Christ-Crain","year":"2007","unstructured":"Christ-Crain M, Stolz D, Jutla S, Couppis O, M\u00fcller C, Bingisser R, et al. Free and total cortisol levels as predictors of severity and outcome in Community-acquired pneumonia. Am J Respir Crit Care Med. 2007;176(9):913\u201320.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"193_CR33","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1183\/09031936.00104412","volume":"41","author":"M Kolditz","year":"2013","unstructured":"Kolditz M, Ewig S, H\u00f6ffken G. Management-based risk prediction in community-acquired pneumonia by scores and biomarkers. Eur Respir J. 2013;41(4):974\u201384.","journal-title":"Eur Respir J"},{"key":"193_CR34","doi-asserted-by":"crossref","unstructured":"Sibila O, Restrepo MI. Biomarkers in community-acquired pneumonia: still searching for the one. Eur Res J [Internet]. 2019 Feb 28;53(2). Available from: https:\/\/publications.ersnet.org\/content\/erj\/53\/2\/1802469. cited 4 Dec 2025.","DOI":"10.1183\/13993003.02469-2018"},{"issue":"3","key":"193_CR35","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1164\/rccm.200406-808OC","volume":"171","author":"M Confalonieri","year":"2005","unstructured":"Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med. 2005;171(3):242\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"193_CR36","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"C Wu","year":"2020","unstructured":"Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934\u201343.","journal-title":"JAMA Intern Med"},{"issue":"5","key":"193_CR37","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s00134-020-06022-5","volume":"46","author":"W Alhazzani","year":"2020","unstructured":"Alhazzani W, M\u00f8ller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med. 2020;46(5):854\u201387.","journal-title":"Intensive Care Med"},{"issue":"8","key":"193_CR38","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"Dexamethasone in Hospitalized Patients with Covid-19","year":"2021","unstructured":"Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021;384(8):693\u2013704.","journal-title":"N Engl J Med"},{"issue":"13","key":"193_CR39","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1001\/jama.2020.17023","volume":"324","author":"JAC Sterne","year":"2020","unstructured":"WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, et al. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: A Meta-analysis. JAMA. 2020;324(13):1330\u201341.","journal-title":"JAMA"},{"key":"193_CR40","unstructured":"Torres A, Motos A, Cill\u00f3niz C, Ceccato A, Fern\u00e1ndez-Barat L, Gabarr\u00fas A, et al. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study. Intensive Care Med. 2022."},{"issue":"11","key":"193_CR41","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1164\/rccm.202105-1302OC","volume":"204","author":"P Sinha","year":"2021","unstructured":"Sinha P, Furfaro D, Cummings MJ, Abrams D, Delucchi K, Maddali MV, et al. Latent class analysis reveals COVID-19-related acute respiratory distress syndrome subgroups with differential responses to corticosteroids. Am J Respir Crit Care Med. 2021;204(11):1274\u201385.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"193_CR42","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1097\/CCM.0000000000004093","volume":"48","author":"LE Lansbury","year":"2020","unstructured":"Lansbury LE, Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Shen Lim W. Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and Meta-analysis. Crit Care Med. 2020;48(2):e98\u2013106.","journal-title":"Crit Care Med"},{"issue":"9","key":"193_CR43","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1007\/s00134-018-5332-4","volume":"44","author":"G Moreno","year":"2018","unstructured":"Moreno G, Rodr\u00edguez A, Reyes LF, Gomez J, Sole-Violan J, D\u00edaz E, et al. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study. Intensive Care Med. 2018;44(9):1470\u201382.","journal-title":"Intensive Care Med"},{"key":"193_CR44","doi-asserted-by":"crossref","unstructured":"Calfee CS, Delucchi K, Parsons PE, Thompson BT, Ware LB, Matthay MA. Latent class analysis of ARDS subphenotypes: analysis of data from two randomized controlled trials. Lancet Respir Med. 2014;2(8):611\u201320.","DOI":"10.1016\/S2213-2600(14)70097-9"},{"issue":"12","key":"193_CR45","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/S2213-2600(20)30366-0","volume":"8","author":"P Sinha","year":"2020","unstructured":"Sinha P, Calfee CS, Cherian S, Brealey D, Cutler S, King C, et al. Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study. Lancet Respir Med. 2020;8(12):1209\u201318.","journal-title":"Lancet Respir Med"},{"issue":"159","key":"193_CR46","doi-asserted-by":"publisher","first-page":"200317","DOI":"10.1183\/16000617.0317-2020","volume":"30","author":"LDJ Bos","year":"2021","unstructured":"Bos LDJ, Artigas A, Constantin JM, Hagens LA, Heijnen N, Laffey JG, et al. Precision medicine in acute respiratory distress syndrome: workshop report and recommendations for future research. Eur Respir Rev. 2021;30(159):200317.","journal-title":"Eur Respir Rev"},{"issue":"1","key":"193_CR47","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13054-024-04876-5","volume":"28","author":"A Ceccato","year":"2024","unstructured":"Ceccato A, Forne C, Bos LD, Camprub\u00ed-Rimblas M, Areny-Balaguer\u00f3 A, Campa\u00f1a-Duel E, et al. Clustering COVID-19 ARDS patients through the first days of ICU admission. An analysis of the CIBERESUCICOVID cohort. Crit Care. 2024;28(1):91.","journal-title":"Crit Care"},{"issue":"3","key":"193_CR48","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1164\/rccm.202406-1241OC","volume":"211","author":"RBE van Amstel","year":"2025","unstructured":"van Amstel RBE, Bartek B, Vlaar APJ, Gay E, van Vught LA, Cremer OL, et al. Temporal transitions of the hyperinflammatory and hypoinflammatory phenotypes in critical illness. Am J Respir Crit Care Med. 2025;211(3):347\u201356.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"193_CR49","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1007\/s00134-025-08089-4","volume":"51","author":"J Pensier","year":"2025","unstructured":"Pensier J, Fosset M, Paschold BS, von Wedel D, Redaelli S, Braeuer BLP, et al. Temporal stability of phenotypes of acute respiratory distress syndrome: clinical implications for early corticosteroid therapy and mortality. Intensive Care Med. 2025;51(10):1784\u201396.","journal-title":"Intensive Care Med"},{"issue":"1","key":"193_CR50","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s41479-025-00180-0","volume":"17","author":"F Salton","year":"2025","unstructured":"Salton F, Villar J, Mondoni M, Harari S, Salotti A, Ambr\u00f3s A, et al. Existence and relevance of fulminant severe community-acquired pneumonia. Pneumonia. 2025;17(1):26.","journal-title":"Pneumonia"}],"container-title":["Pneumonia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41479-025-00193-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41479-025-00193-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41479-025-00193-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:03:29Z","timestamp":1771977809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41479-025-00193-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["193"],"URL":"https:\/\/doi.org\/10.1186\/s41479-025-00193-9","relation":{},"ISSN":["2200-6133"],"issn-type":[{"value":"2200-6133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}